Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Livmarli. Always confirm against the full prescribing information.
11 interactions
Cholestyramine
The therapeutic efficacy of Maralixibat can be decreased when used in combination with Cholestyramine.
Level 1 evidence
Colesevelam
The therapeutic efficacy of Maralixibat can be decreased when used in combination with Colesevelam.
Level 1 evidence
Colestipol
The therapeutic efficacy of Maralixibat can be decreased when used in combination with Colestipol.
Level 1 evidence
Sevelamer
The therapeutic efficacy of Maralixibat can be decreased when used in combination with Sevelamer.
Level 1 evidence
Asunaprevir
The therapeutic efficacy of Asunaprevir can be decreased when used in combination with Maralixibat.
Level 1 evidence
Atorvastatin
The therapeutic efficacy of Atorvastatin can be decreased when used in combination with Maralixibat.
Level 1 evidence
Fexofenadine
The therapeutic efficacy of Fexofenadine can be decreased when used in combination with Maralixibat.
Level 1 evidence
Leflunomide
The risk or severity of liver damage can be increased when Maralixibat is combined with Leflunomide.
Level 1 evidence
Mesalazine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Maralixibat.
Level 1 evidence
Teriflunomide
The risk or severity of liver damage can be increased when Maralixibat is combined with Teriflunomide.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Livmarli
Livmarli (Maralixibat Chloride) has 11 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Livmarli (Maralixibat Chloride) has 1 major, 4 moderate, and 6 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Livmarli. Always confirm against the full prescribing information.